Brief: Oryzon Q1 Net Loss 1.7 Mln Euros
12/05/2025 06:55
May 12 (Reuters) - Oryzon Genomics SA ORY.MC: Q1 NET LOSS 1.7 MILLION EUROS Source text: ID:nCNM7vcGmH Further company coverage: ORY.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28